SCREENING FOR ANTIMICROBIAL ACTIVITY OF SOME MEDICINAL PLANTS IN SAUDI ARABIA
Abstract
Our study aimed to evaluate antimicrobial activities of some medicinal plants against some pathogenic yeasts and fungi. The antimicrobial activities of water and organic crude extracts of 6 medicinal plants used In traditional Saudi Arabia medicine was tested against to and pathogenic yeasts and fungi including strains that were highly resistant to amphotericin B and ketoconazole. Two species of yeasts: Candida albicans and C. tropicals and five species of pathogenic fungi: Aspergillus flavus, Alterneria solani, Fusarium oxisporium, Trichphyton rubrum, T. mentagrophyte and Microsporum nanum were used. Of the 6 plants tested, 5 showed antifungal activities against one or more spe-cies of fungi and 4 showed excellent activity against Candida albicans and C. tropicals. The most active antimicrobial plants were the ethanolic extract of Azadirachta indica(neem), Zingiber officinale (ginger) Eucalyptus globules and Lawsonia inermis with minimal inhibitory concentration (MIC) values ranged from 100 -250 μg/ml. Rosmarinus officinalis and Lepidium sativum have moderate antifungal activates with MIC of 400 μg/ml. No toxicity was recorded up to 300 μg/ml. Moderate toxicity was recorded at 500 μg/ml for A. indica and at 600 μg/ml for E. globules. No antitumor activities were recorded using the Biochemical induction assay (BIA) and Escherichia coli as a test organism.Published
How to Cite
Issue
Section
License
Copyright: Creative Commons Attribution CC.
This license lets others distribute, remix, tweak, and build upon your work, even commercially, as long as they credit you for the original creation. This is the most accommodating of licenses offered. Recommended for maximum dissemination and use of licensed materials. View License Deed | View Legal Code Authors can also self-archive their manuscripts immediately and enable public access from their institution's repository. This is the version that has been accepted for publication and which typically includes author-incorporated changes suggested during submission, peer review and in editor-author communications.